Timolol maleate in the treatment of glaucoma simplex and glaucoma capsulare. A three-year follow up study.

Abstract

180 eyes of 97 patients with primary open angle glaucoma and IOP greater than 22 mm were treated for more than 3 years with timolol-maleate. 130 eyes had glaucoma simplex, and 50 eyes had glaucoma capsulare. With timolol maleate as the only medication after 3 years, the IOP was controlled in 33% of the glaucoma simplex group, and in 8% of the glaucoma capsulare group. No serious local or systemic side-effects were observed.

• Authors: S Blika, E Saunte
• Journal: Acta ophthalmologica (Acta Ophthalmol (Copenh)) Vol. 60 Issue 6 Pg. 967-76 (Dec 1982) ISSN: 0001-639X [Print] Denmark
• PMID: 7170939 (Publication Type: Journal Article)

Chemical References

• Propanolamines
• Timolol

Topics

• Aged
• Drug Therapy, Combination
• Female
• Follow-Up Studies
• Glaucoma (drug therapy)
• Glaucoma, Open-Angle (drug therapy)
• Humans
• Male
• Middle Aged
• Propanolamines (therapeutic use)
• Timolol (therapeutic use)
• Visual Fields